NF-kB transcription factor is activated upon ubiquitination and subsequent proteolysis of its inhibitor IkB. The phosphorylation-dependent ubiquitination is mediated by SCF E3 ubiquitin ligase. In this study, we identi®ed a novel murine F-box/WD40 repeat-containing protein, mHOS (a homologue of HOS/bTrCP2). mHOS eciently binds Skp1 protein (a`core' component of SCF ubiquitin ligase), and phosphorylated IkBa. We found that mHOS associates with SCF-ROC1 E3 ubiquitin ligase activity. We have also observed that mHOS is overexpressed in chemically-induced mouse skin tumors, and its overexpression (but not accelerated IkB phosphorylation) coincides with the accelerated degradation of IkB in vivo. The role of mHOS in the constitutive activation of NF-kB in skin carcinogenesis is discussed.
Introduction
Nuclear factor kappa-B (NF-kB) controls the transcription of an exceptionally large number of genes involved in the regulation of apoptosis (Baichwal and Sonenshein, 1997) , and immune and in¯ammatory responses Barnes et al., 1997; Siebenlist et al., 1994) . In unstimulated cells, NFkB is bound to inhibitory IkB proteins, which sequester NF-kB in its inactive form in the cytoplasm. Stimulation leads to the rapid phosphorylation of IkB proteins. Phosphorylation of IkBa at Ser32,36 provides the speci®c targeting signal that is recognized by IkB-ubiquitin ligase (Yaron et al., 1997) . Ubiquitination and subsequent proteasome-dependent degradation of IkB results in the translocation of NF-kB into the nucleus and realization of NF-kB transcriptional potential (Verma and Stevenson, 1997) .
NF-kB plays an important role in oncogenesis and promotes cell resistance to anti-cancer therapy. Various human cancers demonstrate up-regulated NF-kB activities. Members of the NF-kB and IkB families are associated with chromosomal translocations in certain lymphomas (Zhang et al., 1997) . There is growing evidence that the regulation of IkB and modulation of NF-kB activity may play an important role in controlling cellular proliferation.
An anti-apoptotic eect of NF-kB is suggested among the mechanisms implicated in NF-kB-driven transformation. NF-kB has been shown to be capable of blocking apoptosis induced by TNFa, ionizing radiation, and chemotherapeutic agents. (LaCasse et al., 1998) . Inhibition of NF-kB activities by degradation-de®cient IkB constructs, dramatically potentiates apoptosis of cancer cells induced by various proapoptotic stimuli. Expression of an IkB`superrepressor' has also rendered hepatocytes sensitive to TNFainduced apoptosis, showing that NF-kB activation is the critical intracellular signal that determines whether TNFa stimulates hepatocyte proliferation or death (Xu et al., 1998) . Moreover, NF-kB activation has been shown to be an indispensable event in Ras-induced cellular transformation (Finco et al., 1997; Jo et al., 2000; Mayo et al., 1997) . We have previously shown that murine skin tumors, derived from the two-stage chemical carcinogenesis protocol, exhibit constitutive activation of NF-kB (Budunova et al., 1999) . These tumors are also characterized by mutational activation and overexpression of Ha-ras (DiGiovanni et al., 1993; Pelling et al., 1986 Pelling et al., , 1987 Pelling et al., , 1988 Rodriguez-Puebla et al., 1999) , and, therefore, NF-kB activation seems to be a necessary step in mouse skin carcinogenesis.
Ubiquitination and proteasome-dependent degradation of IkB represent a major event in the regulation of NF-kB signaling pathway. Recent genetic and biochemical studies in yeast and mammalian cells have identi®ed a class of E3 ubiquitin ligases, termed Skp1/ Cull1/F box (SCF) complex, which are required for the degradation of cyclins and their inhibitors, transcription factors, and components of dierent signal transduction pathways. The SCF complexes consist of invariable components (`core' Ub ligase) and variable components called F-box proteins. F-box motif (®rst found in cyclin F) serves for the binding to Skp1 and another protein ± protein interaction motif that recog-nizes a target protein (usually phosphorylated). Therefore, F-box proteins are the speci®c component of the SCF complexes that serve as a receptor for E3 ubiquitin ligase (reviewed in Deshaies, 1999) .
The ubiquitination of IkB is targeted by a family of F-box/WD40 repeat-containing proteins which include Slimb, bTrCP and HOS (bTrCP2). Seven WD40 repeats of Hos/bTrCP serve to recognize the DS(PO3)GXS(PO3) motif on IkB and recruit Skp1-Cullin1-F-box(SCF)-Roc1 E3 ubiquitin ligase Hart et al., 1999; Hatakeyama et al., 1999; Jiang and Struhl, 1998; Kitagawa et al., 1999; Kroll et al., 1999; Latres et al., 1999; Liu et al., 1999; Margottin et al., 1998; Spencer et al., 1999; Suzuki et al., 1999; Winston et al., 1999; Yaron et al., 1998) , while phosphorylation of IkB is mediated by IkB kinase (IKK) in response to various extracellular stimuli (reviewed in Verma and Stevenson, 1997) .
The alteration of HOS/bTrCP function aects the stability of IkB and consequently NF-kB-dependent transcriptional output. Since ubiquitination of IkB is often a rate-limiting factor, the abundance of HOS (or its homologue bTrCP) may serve as a key point of regulation in transducing signals in the NF-kB pathway. Indeed, we have recently shown, that Wnt/ b-catenin, as well as JNK signaling aects NF-kB activation through the regulation of the expression of bTrCP (Spiegelman et al., 2000 (Spiegelman et al., , 2001 .
In this study, we have identi®ed a mouse homologue of HOS(bTrCP2), mHOS. We have characterized mHOS as a part of SCF-Roc1 E3-ubiquitin ligase for IkBa, and revealed its role in constitutive activation of NF-kB in mouse skin tumors.
Results

Identification of mHOS
As a result of BLAST search using a unique N-terminal sequence of human HOS, we identi®ed a recently cloned full-length mouse cDNA (GenBank accession number BF783027). We have sequenced the entire open reading frame and found that it encodes F-box/WD40 repeats-containing protein highly homologous to human HOS (Figure 1 ). It also showed signi®cant homology to another F-box/WD40 repeatcontaining protein, bTrCP, but is dierent in its N-terminal part. These observations indicate that mHOS will likely recognize the substrates, which are targeted by human HOS. High levels of identity between HOS and mHOS allow us to predict that mHOS will associate with Skp1 and function as a receptor of the SCF E3 ubiquitin ligase in mouse cells.
mHOS binds Skp1 and phosphorylated IkBa
Since we have identi®ed an F-box motif in the mHOS sequence, we hypothesized that mHOS may be a component of SCF-ROC1 E3 ubiquitin ligase. Indeed, in vitro translated mHOS exhibited ecient binding to Skp1, a core component of SCF ubiquitin ligase (Figure 2 ). These results indicate that mHOS is very likely to be associated with ubiquitin ligase activity.
WD40 repeats of proteins highly homologous to mHOS (mbTrCP, HOS) recognize IkBa, when phosphorylated by IKK on Serines 32 and 36 Yaron et al., 1998) . In vitro translated mHOS binds to GST-IkBa phosphorylated by IKKb. This binding occurs in an IKK-and ATP-dependent manner (Figure 2 ). The weak binding observed without the addition of ATP is probably due to low amounts of ATP from the reticulocyte lysates present in the reaction. These experiments demonstrate that mHOS speci®cally recognizes phosphorylated IkB. Our data suggest that mHOS is capable of targeting IkB for ubiquitination and degradation in mouse cells.
mHOS is associated with ubiquitin-ligase activity
In order to con®rm that mHOS is associated with ubiquitin-ligase activity, we expressed HA-tagged mHOS together with Skp1, Cul1, and ROC1 in 293T cells. Cell lysates were subjected to immunoprecipitation with anti HA antibody and assayed for ubiquitin ligase activity in the presence of ubiquitin-activating enzyme (E1), ubiquitin conjugating enzyme (E2) and HA-tagged ubiquitin as previously described (Wu et al., 2000) . As seen in Figure 3 , only mHOS-containing immunoprecipitates were capable of generating a high molecular weight smear ( Figure 3 , lane 3), which is characteristic of poly-ubiquitinated proteins. This result indicates that mHOS is associated with ubiquitin-ligase activity. The ligase activity was sensitive to the presence of both E1 (data not shown), and E2 ( Figure 3 , lane 4). These data indicate that mHOS may function as a receptor of the SCF mHOS -ROC1 E3 ubiquitin ligase.
mHOS is overexpressed in mouse skin tumors
We examined the levels of mHOS mRNA in mouse skin tumors induced by the standard two-stage initiation-promotion mouse skin carcinogenesis protocol in SENCAR mice. Northern blot analysis showed that levels of mHOS mRNA were elevated in mouse papillomas and squamous cell carcinomas, when compared to normal mouse epidermis ( Figure 4a ). These data suggest that mHOS is up regulated during mouse skin tumorigenesis. We also found that the expression of bTrCP in these tissues was undetectable by Northern blot analysis (data not shown), which indicates that mHOS is a major component of SCF mHOS/bTrCP ubiquitin ligase in mouse skin tumors. In order to analyse mHOS protein expression, we used rabbit polyclonal antibody raised against human HOS (Spiegelman et al. unpublished data) . Immunoblot analysis revealed a substantial increase in mHOS protein levels in skin tumors, especially in papillomas ( Figure 4b ). Immunohistochemistry con®rmed the overexpression of mHOS in tumors, and also showed the primarily cytoplasmic localization of mHOS Our data demonstrate that mHOS is overexpressed during mouse skin carcinogenesis. We have previously shown that mouse skin papillomas and squamous cell carcinomas (SCC) exhibit elevated NF-kB activity (Budunova et al., 1999) . The high level of mHOS in Figure 1 Comparison of open reading frames of mHOS, human HOS, and mouse bTrCP. Homologous regions of all three proteins are in dark gray, homology between two proteins in light gray. F-box region is boxed, WD40 repeats are underlined and numbered. The coding sequence of this murine homologue of HOS (mHOS) has been deposited in GenBank database (accession number AY038079)
Oncogene mHOS overexpression in skin tumors N Bhatia et al these tumors might be one of the factors contributing to NF-kB activation.
NF-kB is constitutively activated in mouse skin tumors primarily due to up regulation of SCF mHOS ubiquitin ligase Immunohistochemistry of normal skin and skin tumors with polyclonal antibodies against p65(RelA) subunit of NF-kB showed very little (if any) nuclear staining in normal skin keratinocytes. In contrast, numerous less dierentiated epithelial cells (similar to the basal and suprabasal keratinocytes in skin) in papillomas and SCCs exhibited p65 nuclear staining (Figure 5a ), which coincides with mHOS overexpression in the same type of cells ( Figure 4c ). P65 nuclear localization was more pronounced in papillomas, although a substantial increase was also observed in SCCs. These data are in agreement with our previous observations of constitutive activation of NF-kB, measured by electrophoretic mobility shift assay (EMSA) (Budunova et al., 1999) . In order to ®nd out whether signi®cant changes in mHOS protein expression could be the primary cause of the NF-kB activation in mouse skin tumors, we analysed the phosphorylation and degradation of IkBa.
Immunoblot analysis showed a moderate decrease in IkBa level in papillomas (Figure 5b ). In vitro degradation assay also revealed an accelerated degradation of recombinant IkBa using protein extracts from tumors when compared to normal skin ( Figure  5c ). This increased degradation and decreased levels of IkB did not correlate with its phosphorylation. An in vitro kinase assay showed that phosphorylation of IkBa is slightly elevated only in SCC, and does not change in papillomas (Figure 5d ). The level of IKKb protein is also somewhat increased in SCCs. Immunoblot analysis using phospho-speci®c IkBa antibodies con®rmed the slight increase in IkBa phosphorylation only in SCCs (Figure 5b ). Dramatic loss of phosphoIkBa in papillomas exceeded the decreased levels of total IkBa. Moreover, we were able to substantially accelerate IkBa degradation in protein extracts from normal skin by supplementing it with extracts from 293T cells transfected with HOS. Addition of extracts, containing dominant negative HOS (HOS DF ) strikingly delayed IkBa degradation (Figure 5e ). Overall these data suggest that activation of NF-kB in mouse skin tumors strongly correlates with IkB degradation and is likely attributed to the over-expression of mHOS protein.
Discussion
Sequence analysis of the entire open reading frame of mHOS showed that this newly-identi®ed protein belongs to the family of F-box/WD40 repeat-containing proteins. It bears a very high homology to the human HOS, and the only other known mouse member of this family, mbTrCP (FWD1). Although the latter is signi®cantly dierent in its N-terminus, the F-box and WD40 repeats in mbTrCP, human HOS, and mHOS are almost identical (Figure 1) . These sequence data demonstrate that HOS proteins are very conserved between dierent mammals (human and mouse), and we can expect that they have similar biochemical properties and physiological functions. This may prove to be very useful in studying the function of HOS in vivo, bearing in mind the variety of available mouse models of human diseases, as well as Immunoblot analysis. Protein samples from normal skin, papillomas, and SCCs were solubilized in SDS ± PAGE sample buer, heated at 1008C for 5 min, and loaded onto 8% SDS ± PAGE. The resolved proteins were blotted onto nitrocellulose paper, and the blots probed with anti HOS polyclonal antibodies. After washing, membranes were incubated with peroxidase-conjugated anti-goat IgG (Sigma St. Louis, MO, USA). An ECL Western blotting detection kit (Amersham, UK) was used to detect bands. A representative ®gure of three independent experiments is shown. (c) Immunohistochemistry of normal mouse skin and skin tumors using rabbit polyclonal HOS-speci®c antibodies, followed by biotinylated anti-rabbit IgG, and ®nally horseradish peroxidase. Diaminobenzidine was used as a substrate for the peroxidase reaction. To visualize nuclei, sections were also counterstained with hematoxylin. 4006magni®cation the possibilities to develop transgenic and knockout animals with altered HOS function. Indeed, mHOS eciently binds Skp1 protein in vitro (Figure 2 ), strongly suggesting that it is a component of the mammalian SCF-ROC1 complex. Other members of the F-box/WD40 repeat-containing protein family (bTrCP, HOS, mbTrCP(FWD1)) are the substrate recognition components of SCF-ROC1 ubiquitin ligases, which recognize phosphorylated IkB, b-catenin, ATF4, and Vpu proteins. HOS/bTrCP proteins were also shown to target ubiquitination and subsequent proteasome-dependent degradation of IkBa, b-catenin, ATF4 and Vpu-bound CD4 receptor Hart et al., 1999; Hatakeyama et al., 1999; Jiang and Struhl, 1998; Kitagawa et al., 1999; Kroll et al., 1999; Latres et al., 1999; Liu et al., 1999; Margottin et al., 1998; Spencer et al., 1999; Suzuki et al., 1999; Winston et al., 1999; Yaron et al., 1998) . In this study we have also shown, that the newly identi®ed member of this protein family, mHOS, recognizes IkBa, phosphorylated by IKKb (Figure 2 ). The ability of mHOS to recognize other substrates remains to be elucidated. Our data demonstrating the association of mHOS with ubiquitin ligase activity (Figure 3) , suggest that mHOS protein serves as a receptor for SCF mHOS -ROC1 E3 ubiquitin ligase. The expression and function of HOS/bTrCP proteins are very important in modulating NF-kB activity. Dominant negative HOS protein backing its F-box domain (HOS DF ), was shown to block NF-kB activity, and to sensitize human melanoma cells to apoptosis Soldatenkov et al., 1999) . On the other hand, overexpression of HOS/ bTrCp leads to accelerated degradation of IkB Kroll et al., 1999) . The expression of bTrCp, induced by Wnt/b-catenin or JNK signaling also resulted in NF-kB activation (Spiegelman et al., 2000 (Spiegelman et al., , 2001 . In this study, we analysed the role of HOS/bTrCP proteins in constitutive activation of NFkB in vivo, utilizing a mouse skin carcinogenesis model. Tumors derived from the two-stage chemical carcinogenesis protocol in SENCAR mice exhibit a high level of constitutive NF-kB activity (Budunova et al., 1999) . We could not detect the expression of the previously characterized mbTrCP(FWD1) mRNA by Northern blot analysis in mouse skin and tumors. Up to 30 mg total RNA, and up to 3 weeks of autoradiograph exposure revealed no visible expression (data not shown). On the other hand, mHOS, characterized in this study, was readily detectable by Northern blots and immunoblots, as well as by immunohistochemistry, and was overexpressed in tumors ( Figure 4) . Interestingly, while the message of mHOS increased to about the same extent in all tumors analysed, the abundance of mHOS protein, assayed by immunoblotting and immunohistochemistry, was the highest in papillomas, with a moderate increase in SCCs. This discrepancy between message and protein elevation in SCCs may be due to posttranscriptional regulation of mHOS expression. For instance, since HOS protein itself undergoes rapid proteasome-dependent degradation , the dierential regulation of its protein stability in dierent tumors may contribute to the mHOS expression pattern. Decreased mHOS translation in SCCs may also explain this observation. This mHOS over-expression in mouse skin tumors appears to be important for NF-kB activation. It coincides with the rate of IkBa degradation both in vitro and in vivo (Figure 5b,c) , and correlates with NF-kB activation assayed by p65 nuclear translocation (Figure 6a) , and by EMSA (Budunova et al., 1999) . At the same time, papillomas that showed the most signi®cant increase in NF-kB activity did not exhibit accelerated IkB phosphorylation, as assayed by IkB kinase asay, or by immunoblotting with phospho-IkBa-speci®c antibody (Figure 5b,d ). In addition, we have shown that we can induce degradation of IkBa in normal skin protein extracts by supplementing it with HOS. On the other hand HOS DF inhibited IkBa degradation under the same conditions (Figure 5e ). Thus, we provide strong evidence that the overexpression of mHOS in mouse skin tumors, especially in papillomas, leads to the constitutive activation of NF-kB. In addition to the moderate elevation of mHOS level, the slight increase in IkB phosphorylation might also contribute to the NF-kB activation in SCCs.
Our data conclusively showed that the newlyidenti®ed member of F-box/WD40 repeat-containing proteins, mHOS, targets phosphorylation-dependent ubiquitination, and degradation of IkBa, and plays a crucial role in NF-kB activation in vivo in chemically induced mouse skin tumors. Future studies will be concentrated on the ability of mHOS to recognize other potential substrates (b-catenin, ATF4 etc.) for ubiquitination. We will also elucidate the role of mHOS in the regulation of turnover of these proteins in vivo: in mouse skin carcinogenesis, and other mouse models of human diseases.
Materials and methods
mHOS isolation and expression vectors
Mouse cDNA clone IMAGE:4237375 (GenBank accession number BF783027) was purchased from Incyte Genomics. Sequence of both strains of the open reading frame was performed at the University of Colorado Cancer Center Sequencing Core using the following primers: SP6, 597 forward: 5'-GGTGTGTAAAGAATGGCAGCG-3'; 597 reverse: 5'-CGCTGCCATTCTTTACACACC-3'; 1052 forward: 5'-GTGTGGGACATGGCTTCTG-3'; 1052 reverse: 5'-CA-GAAGCCATGTCCCACAC-3'; 3' end reverse:
The entire open reading frame of mHOS was ampli®ed by Platinum Pfx DNA polymerase (Life Technologies) using the above mentioned clone as template. In order to produce HAtagged fusion protein, we used HA-modi®ed 5' primer: 5'-GCCACCATGTACCCCTACGACGTCCCCGACTACGC-CGAGCCCGACTCGGTGATTGAAG-3', and the following 3' primer: 5'-GCCGGCGAATTCGATCTGGAGATATAG-GTGTAGGTTCTGGAGGG-3'.
The PCR product was then subcloned into pUniBlunt/V5-His-TOPO vector and transferred into pcDNA3.1-E expression vector using Echo Cloning system (Invitrogen), according to the manufacturer's protocol.
In vitro binding of mHOS to Skp1 and IkBa
GST-Skp1 and GST-IkBa (1 ± 54) fusion proteins were produced in E. coli using respective bacterial expression constructs (gifts of R Deshaies and M Karin). Beads-bound fusion proteins were incubated with in vitro translated and 35 S-methionine-labeled mHOS (9 ml) in the presence or absence of HA-IKKb se (Tan et al., 1999) and 10 mM ATP as indicated.
Ubiquitin ligase activity
293T human embryo kidney cells were transfected with the indicated plasmids (5 mg each) by calcium precipitate method and harvested 48 h later. The lysates were prepared and immunoprecipitated with anti-HA monoclonal antibody (12CA5, Roche) as described earlier (Wu et al., 2000) . The immunoprecipitates were incubated with HA-tagged ubiquitin (2 mg) in the presence of E1 (0.2 mg, a gift of Victor Fried), Ubc5c (0.5 mg), and 2 mM ATP for 60 min at 378C. The reaction was stopped by boiling in Laemmli buer and analysed by SDS ± PAGE, protein transfer and immunoblotting with anti-HA antibody.
Two-stage mouse skin carcinogenesis
In our experiments we used a standard two-stage initiationpromotion mouse skin carcinogenesis protocol. The dorsal skin of female SENCAR mice (National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD, USA) in the resting stage of the hair cycle (8 ± 10 weeks of age) was shaved and initiated 3 days later with DMBA (10 nmol/ mouse in 200 ml of acetone). Promotion with TPA (2 mg/ mouse, twice a week) started 2 weeks after initiation and continued for 60 weeks. Tumors (papillomas and carcinomas) were harvested every 10 weeks, starting from the tenth week of promotion. To avoid the direct eect of TPA on the studied parameters, the mice were sacri®ced 2 weeks after the last treatment with tumor promoter. These tumors were used for analyses described below.
Northern blot analysis
Twenty mg of total RNA isolated from normal mouse epidermis (E) and tumors using TRI-reagent (Molecular Research Center, Cincinnati, OH, USA) was subjected to Northern blotting analysis using random primer-labeled probes for unique N-terminal parts of mHOS and mbTrCP. The membranes were stripped and re-hybridized with a probe to 7S RNA to verify that equal amounts of RNA are loaded and transferred.
Immunoblot analysis
Antibodies against HOS will be described elsewhere (Spiegelman et al. unpublished data). For detection of endogenous HOS, 500 mg of protein lysates were immunoprecipitated with anti-HOS-C antibody (1 mg), separated on 8% SDS ± PAGE, transferred onto a nitrocellulose membrane and probed with anti-HOS antibody at 1 : 1000 dilution.
For detecting endogenous IkBa, phospho-IkBa, and IKKb 50 mg of protein lysates were separated on 10% SDS ± PAGE, transferred onto a nitrocellulose membrane and probed with IkBa antibody (Santa Cruz) at 1 : 1000 dilution or with phospho-IkBa antibody (New England Biolabs) at 1 : 1000 dilution, or with IKKb antibody (Santa Cruz) at 1 : 1000 dilution. Loading of cell lysates on gels was normalized for protein concentration. Membranes were developed with the ECL kit (Amersham) and exposed to ®lm.
Immunohistochemistry
Skin and tumor samples were ®xed in formalin for mHOS immunostaining or in methacarn for p65 immunostaining, paran blocks were prepared and sections were cut in the core facility at AMC Cancer Research Center. Sections were deparanized in three changes of xylene and hydrated in grades of alcohols followed by 30 min incubation in 1% H 2 O 2 in methanol to block endogenous peroxidase activity.
Antigen retrieval was performed by subjecting the slides to 10 min in microwave in 10 mM citrate buer. Slides were blocked in blocking buer (2.5% horse serum) for 1 h and overnight incubation with anti-HOS polyclonal antibody (1 : 200 dilution in blocking buer), or anti-p65 polyclonal antibody (Santa Cruz, sc-109, 1 : 250 dilution in blocking buer). Slides were incubated with biotinylated anti-rabbit IgG (1 : 500 in blocking buer) followed by ABC reagent (Vector Laboratories, Burlingame, CA, USA). Diaminobenzidine was used as a chromogenic substrate for 10 ± 30 min. Sections were counterstained with hematoxylin after immunostaining.
Solid phase protein kinase activity assay IKK activity in whole cell extracts (10 mg) was assessed in the solid phase kinase assay with bacterially expressed GST-IkB (amino acids 1 ± 54) in the presence of [g-32 P]-ATP (50 c.p.m./ fmol) as described elsewhere (Spiegelman et al., 2000) .
IkBa degradation in vitro
Nucleic acid sequence fragments encoding Flag-tagged IkBa (wt and DN) were excised from pCMV4-Flag-IkBa constructs (a kind gift of Dean Ballard) with HindIII and SmaI restriction enzymes and ligated with the HindIII/SmaI digested Bluescript SK+ (Stratagene). The resulting plasmids were used for in vitro translation (T7 TnT, Promega) in the presence of 35 S-methionine (Amersham). To assess the rate of IkBa degradation in vitro, labeled IkBa and IkBaDN (1 ml each) were incubated with 150 mg of whole tissue extract in the presence of 2 mM ATP, 5 mM MgCl 2 , 60 mM creatine phosphate, 2 units creatine phosphokinase, 1 mM NaVO 4 , 50 mM okadaic acid, and 1 mg ubiquitin at 378C for the indicated time points. Degradation of 35 S-labeled IkBa was monitored by SDS ± PAGE and autoradiography. Tissue extracts were prepared by quick homogenization of mouse tissues in 50 mM Tris (pH 7.5) and 1 mM DTT. The lysates were frozen and thawed three times followed by centrifugation at 14 000 r.p.m. at 48C. Supernatants were divided into aliquots and stored at 7808C.
